ERBB2 and breast carcinoma: For example, while prior biopsy and atypical hyperplasia are strongly associated with ER/PR + HER2 − breast cancers and are included in several existing breast cancer risk prediction models [6–9], there appears to be no association between these factors and TNBC [5].